vs
ADMA BIOLOGICS, INC.（ADMA）与DigitalOcean Holdings, Inc.（DOCN）财务数据对比。点击上方公司名可切换其他公司
DigitalOcean Holdings, Inc.的季度营收约是ADMA BIOLOGICS, INC.的1.7倍（$242.4M vs $139.2M），ADMA BIOLOGICS, INC.净利率更高（35.5% vs 10.6%，领先24.9%），ADMA BIOLOGICS, INC.同比增速更快（18.4% vs 18.3%），ADMA BIOLOGICS, INC.自由现金流更多（$34.6M vs $31.1M），过去两年ADMA BIOLOGICS, INC.的营收复合增速更高（30.4% vs 14.5%）
ADMA生物制剂公司是一家专注于研发、生产及商业化特种血浆来源免疫球蛋白疗法的生物制药企业，主要面向美国市场，为原发性免疫缺陷及其他免疫相关疾病患者、医护人员和医疗机构提供免疫健康领域的治疗方案。
DigitalOcean Holdings, Inc.是美国跨国科技企业及云服务提供商，总部位于美国科罗拉多州布鲁姆菲尔德，在全球布局15个数据中心，面向开发者、初创企业及中小微企业提供稳定易用的云基础设施即服务平台，助力各类技术团队高效开展业务。
ADMA vs DOCN — 直观对比
营收规模更大
DOCN
是对方的1.7倍
$139.2M
营收增速更快
ADMA
高出0.1%
18.3%
净利率更高
ADMA
高出24.9%
10.6%
自由现金流更多
ADMA
多$3.4M
$31.1M
两年增速更快
ADMA
近两年复合增速
14.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $139.2M | $242.4M |
| 净利润 | $49.4M | $25.7M |
| 毛利率 | 63.8% | 58.7% |
| 营业利润率 | 45.1% | 16.0% |
| 净利率 | 35.5% | 10.6% |
| 营收同比 | 18.4% | 18.3% |
| 净利润同比 | -55.9% | 40.5% |
| 每股收益（稀释后） | $0.20 | $0.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADMADOCN
| Q4 25 | $139.2M | $242.4M | ||
| Q3 25 | $134.2M | $229.6M | ||
| Q2 25 | $122.0M | $218.7M | ||
| Q1 25 | $114.8M | $210.7M | ||
| Q4 24 | $117.5M | $204.9M | ||
| Q3 24 | $119.8M | $198.5M | ||
| Q2 24 | $107.2M | $192.5M | ||
| Q1 24 | $81.9M | $184.7M |
净利润ADMADOCN
| Q4 25 | $49.4M | $25.7M | ||
| Q3 25 | $36.4M | $158.4M | ||
| Q2 25 | $34.2M | $37.0M | ||
| Q1 25 | $26.9M | $38.2M | ||
| Q4 24 | $111.9M | $18.3M | ||
| Q3 24 | $35.9M | $32.9M | ||
| Q2 24 | $32.1M | $19.1M | ||
| Q1 24 | $17.8M | $14.1M |
毛利率ADMADOCN
| Q4 25 | 63.8% | 58.7% | ||
| Q3 25 | 56.3% | 59.6% | ||
| Q2 25 | 55.1% | 59.9% | ||
| Q1 25 | 53.2% | 61.4% | ||
| Q4 24 | 53.9% | 57.1% | ||
| Q3 24 | 49.8% | 60.2% | ||
| Q2 24 | 53.6% | 61.0% | ||
| Q1 24 | 47.8% | 60.7% |
营业利润率ADMADOCN
| Q4 25 | 45.1% | 16.0% | ||
| Q3 25 | 38.0% | 19.6% | ||
| Q2 25 | 35.1% | 16.3% | ||
| Q1 25 | 30.4% | 17.9% | ||
| Q4 24 | 32.6% | 15.9% | ||
| Q3 24 | 33.1% | 12.4% | ||
| Q2 24 | 36.6% | 11.6% | ||
| Q1 24 | 26.7% | 6.2% |
净利率ADMADOCN
| Q4 25 | 35.5% | 10.6% | ||
| Q3 25 | 27.1% | 69.0% | ||
| Q2 25 | 28.1% | 16.9% | ||
| Q1 25 | 23.4% | 18.1% | ||
| Q4 24 | 95.2% | 8.9% | ||
| Q3 24 | 30.0% | 16.6% | ||
| Q2 24 | 29.9% | 9.9% | ||
| Q1 24 | 21.7% | 7.7% |
每股收益（稀释后）ADMADOCN
| Q4 25 | $0.20 | $0.23 | ||
| Q3 25 | $0.15 | $1.51 | ||
| Q2 25 | $0.14 | $0.39 | ||
| Q1 25 | $0.11 | $0.39 | ||
| Q4 24 | $0.45 | $0.21 | ||
| Q3 24 | $0.15 | $0.33 | ||
| Q2 24 | $0.13 | $0.20 | ||
| Q1 24 | $0.08 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $87.6M | $254.5M |
| 总债务越低越好 | $72.1M | $1.3B |
| 股东权益账面价值 | $477.3M | $-28.7M |
| 总资产 | $624.2M | $1.8B |
| 负债/权益比越低杠杆越低 | 0.15× | — |
8季度趋势，按日历期对齐
现金及短期投资ADMADOCN
| Q4 25 | $87.6M | $254.5M | ||
| Q3 25 | $61.4M | $236.6M | ||
| Q2 25 | $90.3M | $387.7M | ||
| Q1 25 | $71.6M | $360.4M | ||
| Q4 24 | $103.1M | $428.4M | ||
| Q3 24 | $86.7M | $439.9M | ||
| Q2 24 | $88.2M | $443.1M | ||
| Q1 24 | $45.3M | $419.1M |
总债务ADMADOCN
| Q4 25 | $72.1M | $1.3B | ||
| Q3 25 | $72.4M | $1.3B | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $72.3M | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ADMADOCN
| Q4 25 | $477.3M | $-28.7M | ||
| Q3 25 | $431.2M | $-69.6M | ||
| Q2 25 | $398.3M | $-175.2M | ||
| Q1 25 | $373.4M | $-210.7M | ||
| Q4 24 | $349.0M | $-203.0M | ||
| Q3 24 | $231.9M | $-211.7M | ||
| Q2 24 | $188.3M | $-253.8M | ||
| Q1 24 | $153.7M | $-286.1M |
总资产ADMADOCN
| Q4 25 | $624.2M | $1.8B | ||
| Q3 25 | $568.7M | $1.7B | ||
| Q2 25 | $558.4M | $1.7B | ||
| Q1 25 | $510.6M | $1.6B | ||
| Q4 24 | $488.7M | $1.6B | ||
| Q3 24 | $390.6M | $1.5B | ||
| Q2 24 | $376.4M | $1.5B | ||
| Q1 24 | $350.9M | $1.5B |
负债/权益比ADMADOCN
| Q4 25 | 0.15× | — | ||
| Q3 25 | 0.17× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.6M | $57.3M |
| 自由现金流经营现金流 - 资本支出 | $34.6M | $31.1M |
| 自由现金流率自由现金流/营收 | 24.8% | 12.8% |
| 资本支出强度资本支出/营收 | 0.8% | 10.8% |
| 现金转化率经营现金流/净利润 | 0.72× | 2.23× |
| 过去12个月自由现金流最近4个季度 | $27.8M | $180.5M |
8季度趋势，按日历期对齐
经营现金流ADMADOCN
| Q4 25 | $35.6M | $57.3M | ||
| Q3 25 | $13.3M | $95.8M | ||
| Q2 25 | $21.1M | $92.4M | ||
| Q1 25 | $-19.7M | $64.1M | ||
| Q4 24 | $50.2M | $71.3M | ||
| Q3 24 | $25.0M | $73.4M | ||
| Q2 24 | $45.6M | $71.3M | ||
| Q1 24 | $-2.2M | $66.7M |
自由现金流ADMADOCN
| Q4 25 | $34.6M | $31.1M | ||
| Q3 25 | $-1.1M | $88.0M | ||
| Q2 25 | $18.7M | $59.3M | ||
| Q1 25 | $-24.4M | $2.1M | ||
| Q4 24 | $47.5M | $26.1M | ||
| Q3 24 | $24.0M | $16.0M | ||
| Q2 24 | $43.6M | $39.5M | ||
| Q1 24 | $-4.6M | $23.0M |
自由现金流率ADMADOCN
| Q4 25 | 24.8% | 12.8% | ||
| Q3 25 | -0.8% | 38.3% | ||
| Q2 25 | 15.3% | 27.1% | ||
| Q1 25 | -21.2% | 1.0% | ||
| Q4 24 | 40.4% | 12.7% | ||
| Q3 24 | 20.0% | 8.1% | ||
| Q2 24 | 40.7% | 20.5% | ||
| Q1 24 | -5.6% | 12.5% |
资本支出强度ADMADOCN
| Q4 25 | 0.8% | 10.8% | ||
| Q3 25 | 10.7% | 3.4% | ||
| Q2 25 | 2.0% | 15.2% | ||
| Q1 25 | 4.1% | 29.4% | ||
| Q4 24 | 2.3% | 22.1% | ||
| Q3 24 | 0.9% | 28.9% | ||
| Q2 24 | 1.9% | 16.6% | ||
| Q1 24 | 2.9% | 23.6% |
现金转化率ADMADOCN
| Q4 25 | 0.72× | 2.23× | ||
| Q3 25 | 0.36× | 0.60× | ||
| Q2 25 | 0.62× | 2.50× | ||
| Q1 25 | -0.73× | 1.68× | ||
| Q4 24 | 0.45× | 3.91× | ||
| Q3 24 | 0.70× | 2.23× | ||
| Q2 24 | 1.42× | 3.73× | ||
| Q1 24 | -0.12× | 4.72× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADMA
| ADMA Bio Manufacturing Segment | $123.1M | 88% |
| Other | $16.0M | 12% |
DOCN
| Scalers | $84.3M | 35% |
| Scalers Plus | $69.9M | 29% |
| Builders | $64.1M | 26% |
| Learners Testers And Other | $24.1M | 10% |
